Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CCL4/MIP-1-beta Antibody (SAA0455), PerCP

Catalog #:   FHC96914 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, FCM
Accession: P13236
Overview

Catalog No.

FHC96914

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Conjugation

PerCP

Applications

ELISA, FCM

Target

MIP-1-beta(1-69), MIP-1-beta, C-C motif chemokine 4, Protein H400, ACT-2, HC21, T-cell activation protein 2, Lymphocyte activation gene 1 protein, LAG-1, SIS-gamma, Small-inducible cytokine A4, G-26 T-lymphocyte-secreted protein, Macrophage inflammatory protein 1-beta, LAG1, PAT 744, CCL4, SCYA4, MIP1B

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

P13236

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0455

Note

For research use only.

Data Image
References

Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection., PMID:37903875

Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations., PMID:38090597

Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials., PMID:38108458

Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1/Cosmc pathway., PMID:38151955

The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis., PMID:38203309

Delayed CCL23 response is associated with poor outcomes after cardiac arrest., PMID:38325139

Relationship between serum IgA levels and low percentage forced expiratory volume in the first second in asthma., PMID:38376485

Serum levels of CXCL5 are decreased and correlate with circulating platelet counts in systemic lupus erythematosus., PMID:38439196

CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome., PMID:38449806

Major alteration of Lung Microbiome and the Host Reaction in critically ill COVID-19 Patients with high viral load., PMID:38496464

Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis., PMID:38622321

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease., PMID:38622654

HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses., PMID:38687604

Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection., PMID:38729909

CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation., PMID:38739303

Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate Cancer., PMID:38856749

Rabies Virus Infection Causes Pyroptosis of Neuronal Cells., PMID:38891803

Selection for high and low antibody responses to sheep red blood cells influences cytokine and chemokine expression in chicken peripheral blood leukocytes and splenic tissue., PMID:38936074

Regulatory B Cells Expressing Granzyme B from Tolerant Renal Transplant Patients: Highly Differentiated B Cells with a Unique Pathway with a Specific Regulatory Profile and Strong Interactions with Immune System Cells., PMID:39120317

Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease., PMID:39131287

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes., PMID:39294186

Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption., PMID:39309507

42-parameter mass cytometry panel to assess cellular and functional phenotypes of leukocytes in bronchoalveolar lavage of Rhesus macaque., PMID:39386621

OPN-Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH-Associated Liver Fibrosis., PMID:39473081

Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing., PMID:39483478

Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors., PMID:39513363

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy., PMID:39515328

Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models., PMID:39529885

Major alteration of lung microbiome and the host responses in critically ill COVID-19 patients with high viral load., PMID:39532981

A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates., PMID:39543172

ACBP/DBI neutralization for the experimental treatment of fatty liver disease., PMID:39550516

Double-Negative T Cells Promote Liver Fibrosis Progression by Regulating Treg/Th17., PMID:39575557

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer., PMID:39576210

Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth., PMID:39609412

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI., PMID:39635532

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity., PMID:39654627

Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer., PMID:39758230

CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation., PMID:39791734

Liver oval cells in response to HDAC1 inhibitor trichostatin A: immunohistochemical characterization using OV-6 hepatic expression., PMID:39809587

Upregulation of interferon-γ response genes in monocytes and T cells identified by single-cell transcriptomics in patients with anti-citrullinated peptide antibody-positive early rheumatoid arthritis., PMID:39877346

Interferon-γ production in response to the cytotoxic T lymphocyte epitope within an antigen incorporated in simian virus 40 virus-like particles., PMID:39897799

Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison., PMID:39911484

Identification of novel autoantibodies in Sjögren's disease., PMID:39963128

Comparison of Immune and Systemic Inflammation Parameters in Patients with a Depressive Episode in Bipolar Disorder and Major Depressive Disorder: A Scoping Review., PMID:39980624

Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis., PMID:40173259

Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling., PMID:40260261

Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study., PMID:40329232

IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion., PMID:40371594

Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study., PMID:40404633

Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease., PMID:40468739

Datasheet
$ 238
Product specifications
50 T 238 100 T 394

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CCL4/MIP-1-beta Antibody (SAA0455), PerCP [FHC96914]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2026 AntibodySystem All Rights Reserved.            All Products are for Research Use Only